Skip to main content

Table 1 Summary of reviewed articles

From: Quality of life and emotional distress in advanced prostate cancer survivors undergoing chemotherapy

Authors

Chemotherapeutic agent

QOL measure

Direction of effect

Tannock et al. (1996)

Mitoxantrone

EORTC QLQ-30; Pain rating

Improved pain, mood & physical activity

Beer et al., (2001)

Docetaxel

Present Pain Intensity scale

Improved pain

Sinibaldi et al. (1999)

Docetaxel

Brief Pain Inventory

Improved pain

Copur et al. (2001)

Docetaxel

Numeric rating scale

Improved pain

Gravis et al. (2003)

Docetaxel

EORTC QLQ-30; Pain VAS

Improved role, social functioning, overall QOL, pain, fatigue, constipation

Small et al. (2000)

Suramin

Brief Pain Inventory

Improved pain

Fuse et al. (1996)

Cisplatin/carboplatin

Rating scale

Improved pain

Kreis et al. (1999).

Docetaxel

Physician-graded events

Presence of fatigue dose-limiting factor

Hamilton et al. (2003)

Vinblastine

Physician-graded events

Presence of fatigue dose-limiting factor

van Andel et al. (2003)

Epirubicin

QLQ-30

Reduced fatigue, transient improvement in emotional, social and cognitive functioning

Kornblith et al. (2001)

Docetaxel

FACT-P, Mental Health Inventory-17

Transient improvements in emotional well-being, improved overall QOL